Market Cap
¥2.171 Trillion
JPY as of July 1, 2025
US$15.14 Billion
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Novo Nordisk | $309.91 B | 
|  UnitedHealth Group | $279.90 B | 
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
 Japan
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—Specialty & Generic
                            Japan
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Drug Manufacturers—Specialty & Generic
                     Japan Healthcare
                                Japan Healthcare
                        
                             Japan Drug Manufacturers—Specialty & Generic
                            Japan Drug Manufacturers—Specialty & Generic
                    
                    The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.